Tumor Biology

, Volume 37, Issue 7, pp 9433–9440 | Cite as

HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a

Original Article

Abstract

The aim of this research was to study how HPV-16 E7 affects the proliferation, invasion, and metastasis of oral squamous cell carcinoma (OSCC) cells by upregulating the expression of miR-20a. A total of 60 OSCC patients were included in this study. SiRNA-198 was used to inhibit HPV-16 E7, and the constructed plasmid of HPV-16 E7 was transfected into Cal27 cells. Then, HPV-16 E7 protein was detected by Western blot and RT-PCR was performed to measure miR-20a expression in OSCC cells. Either HPV-16 E7 or the combination of HPV-16 E7 and miR-20a inhibitors was transfected into Cal27 cells separately. And then, the effect of miR-20a on OSCC cells proliferation was evaluated by CCK-8. Moreover, transwell assay and wound healing assay were used to assess the impact of miR-20a on OSCC cell invasion migration. MiR-20a was significantly higher in OSCC tissues compared with para-carcinoma tissues. RT-PCR results indicated that miR-20a was downregulated after silencing HPV-16 E7. By contrast, miR-20a was upregulated after the overexpression of HPV-16 E7. Upregulation of miR-20a by transfected plasmid HPV-16 E7 can significantly inhibit Cal27 cell proliferation, invasion, and migration. The expression of MiR-20a upregulated by HPV-16 E7 inhibits the proliferation, invasion, and migration of OSCC cells.

Keywords

HPV-16 E7 MiR-20a OSCC Proliferation Invasion Migration 

Notes

Acknowledgments

The authors wish to express their appreciation to the reviewers for their critical comments.

Compliance with ethical standard

This research on human subjects was approved by the Ethics Committee of Hospital of Stomatology Affiliated to the Zhejiang University. Written informed consent was obtained from each participant. All experiments were performed in accordance with relevant approved guidelines and regulations of Hospital of Stomatology Affiliated to Zhejiang University.

Conflicts of interest

None

References

  1. 1.
    Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22.CrossRefPubMedGoogle Scholar
  2. 2.
    Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck. 2007;29:779–92.CrossRefPubMedGoogle Scholar
  3. 3.
    Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12:889–96.PubMedGoogle Scholar
  6. 6.
    Kaminagakura E, Villa LL, Andreoli MA, Sobrinho JS, Vartanian JG, Soares FA, et al. High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer. 2012;130:1726–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Marur S, D’Souza G, Westra WH, Forastiere AA. Hpv-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607–15.CrossRefPubMedGoogle Scholar
  9. 9.
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:612–9.CrossRefGoogle Scholar
  10. 10.
    Tran N, Rose BR, O’Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck. 2007;29:64–70.CrossRefPubMedGoogle Scholar
  11. 11.
    Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 e6 proteins with p53. Science. 1990;248:76–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The hpv-16 e6 and e6-ap complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495–505.CrossRefPubMedGoogle Scholar
  13. 13.
    Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol Off J Am Soc Clin Oncol. 1998;16:330–7.CrossRefGoogle Scholar
  14. 14.
    Zhu YK, Cheng N, Hu Y, Cen YZ. The role of micrornas in the pathogenesis of cervical cancer and its relationship to hpv. Sheng Li Ke Xue Jin Zhan. 2012;43:251–6.PubMedGoogle Scholar
  15. 15.
    Huang CG, Lee LA, Tsao KC, Liao CT, Yang LY, Kang CJ, et al. Human papillomavirus 16/18 e7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma. J Clin Virol. 2014;61:230–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Carthew RW, Sontheimer EJ. Origins and mechanisms of mirnas and sirnas. Cell. 2009;136:642–55.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis. 2014;16:2–14.CrossRefPubMedGoogle Scholar
  18. 18.
    Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microrna-218 in cervical carcinoma cells. Oncogene. 2008;27:2575–82.CrossRefPubMedGoogle Scholar
  19. 19.
    Myklebust MP, Bruland O, Fluge O, Skarstein A, Balteskard L, Dahl O. Microrna-15b is induced with e2f-controlled genes in hpv-related cancer. Br J Cancer. 2011;105:1719–25.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA. Alteration of microrna profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck. 2011;33:504–12.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microrna 203 upon epithelial differentiation to control levels of p63 proteins. J Virol. 2010;84:5212–21.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Zhao S, Yao D, Chen J, Ding N. Circulating mirna-20a and mirna-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers. 2013;17:631–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR, Wu TS, et al. Microrna-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol. 2013;49:923–31.CrossRefPubMedGoogle Scholar
  24. 24.
    Hong D, Ye F, Chen H, Lu W, Cheng Q, Hu Y, et al. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer. 2008;18:104–9.CrossRefPubMedGoogle Scholar
  25. 25.
    zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.CrossRefPubMedGoogle Scholar
  26. 26.
    Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96:449–55.CrossRefPubMedGoogle Scholar
  27. 27.
    Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13–21.CrossRefPubMedGoogle Scholar
  28. 28.
    Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, et al. Oncogenic hpv infection interrupts the expression of tumor-suppressive mir-34a through viral oncoprotein e6. RNA. 2009;15:637–47.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Zheng ZM, Wang X. Regulation of cellular mirna expression by human papillomaviruses. Biochim Biophys Acta. 1809;2011:668–77.Google Scholar
  30. 30.
    Zhu H, Han C, Lu D, Wu T. Mir-17-92 cluster promotes cholangiocarcinoma growth: evidence for pten as downstream target and il-6/stat3 as upstream activator. Am J Pathol. 2014;184:2828–39.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Mendell JT. Miriad roles for the mir-17-92 cluster in development and disease. Cell. 2008;133:217–22.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Olive V, Jiang I, He L. Mir-17-92, a cluster of mirnas in the midst of the cancer network. Int J Biochem Cell Biol. 2010;42:1348–54.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, et al. Microrna 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A. 2010;107:8231–6.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Zhuo W, Ge W, Meng G, Jia S, Zhou X, Liu J. Microrna20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression. Mol Med Rep. 2015;12:4989–94.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, et al. Mir-20a promotes proliferation and invasion by targeting app in human ovarian cancer cells. Acta Biochim Biophys Sin. 2010;42:318–24.CrossRefPubMedGoogle Scholar
  36. 36.
    Kang HW, Wang F, Wei Q, Zhao YF, Liu M, Li X, et al. Mir-20a promotes migration and invasion by regulating tnks2 in human cervical cancer cells. FEBS Lett. 2012;586:897–904.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  1. 1.Department of ProsthodonticsHospital of Stomatology Affiliated to Zhejiang UniversityHangzhouPeople’s Republic of China
  2. 2.Department of Maxillofacial SurgeryHospital of Stomatology Affiliated to Zhejiang UniversityHangzhouPeople’s Republic of China
  3. 3.Department of StomatologyTongde Hospital of Zhejiang ProvinceHangzhouPeople’s Republic of China

Personalised recommendations